SLC35C2 anticorps (C-Term)
Aperçu rapide pour SLC35C2 anticorps (C-Term) (ABIN6259278)
Antigène
Voir toutes SLC35C2 (OVCOV1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- SLC35C2 Antibody detects endogenous levels of total SLC35C2.
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human SLC35C2, corresponding to a region within C-terminal amino acids.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Date de péremption
- 12 months
-
-
- SLC35C2 (OVCOV1) (Ovarian Cancer Overexpressed 1 (OVCOV1))
-
Autre désignation
- SLC35C2
-
Sujet
-
Description: May play an important role in the cellular response to tissue hypoxia. May be either a GDP-fucose transporter that competes with SLC35C1 for GDP-fucose, or a factor that otherwise enhances the fucosylation of Notch and is required for optimal Notch signaling in mammalian cells.
Gene: SLC35C2
-
Poids moléculaire
- 40 kDa
-
ID gène
- 51006
-
UniProt
- Q9NQQ7
Antigène
-